Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 10 | 2024 | 3788 | 2.180 |
Why?
|
Myocardial Perfusion Imaging | 9 | 2024 | 669 | 2.140 |
Why?
|
Colchicine | 5 | 2024 | 257 | 2.060 |
Why?
|
Fractional Flow Reserve, Myocardial | 6 | 2024 | 349 | 1.800 |
Why?
|
Pericarditis | 3 | 2024 | 136 | 1.650 |
Why?
|
Coronary Artery Disease | 15 | 2024 | 6575 | 1.630 |
Why?
|
Myocardial Ischemia | 4 | 2023 | 2131 | 1.490 |
Why?
|
Coronary Circulation | 10 | 2024 | 1602 | 1.460 |
Why?
|
Troponin T | 4 | 2024 | 786 | 1.460 |
Why?
|
Cardiovascular Diseases | 16 | 2024 | 15652 | 1.440 |
Why?
|
Antirheumatic Agents | 4 | 2024 | 1383 | 1.400 |
Why?
|
Psoriasis | 4 | 2023 | 925 | 1.370 |
Why?
|
Atherosclerosis | 5 | 2024 | 3421 | 1.250 |
Why?
|
Rheumatic Diseases | 3 | 2024 | 657 | 1.230 |
Why?
|
Heart Auscultation | 2 | 2017 | 33 | 1.080 |
Why?
|
Anti-Inflammatory Agents | 5 | 2024 | 1805 | 0.990 |
Why?
|
Microcirculation | 4 | 2024 | 1282 | 0.990 |
Why?
|
Inflammation | 12 | 2024 | 10863 | 0.960 |
Why?
|
Chloroquine | 1 | 2024 | 276 | 0.830 |
Why?
|
Systemic Vasculitis | 1 | 2023 | 37 | 0.820 |
Why?
|
Heart Diseases | 4 | 2024 | 2817 | 0.810 |
Why?
|
Rheumatology | 2 | 2024 | 619 | 0.700 |
Why?
|
Hydroxychloroquine | 1 | 2024 | 427 | 0.690 |
Why?
|
Heart Injuries | 1 | 2021 | 207 | 0.670 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 2024 | 2160 | 0.650 |
Why?
|
Inflammation Mediators | 3 | 2024 | 1889 | 0.650 |
Why?
|
Coronary Vessels | 6 | 2024 | 3115 | 0.610 |
Why?
|
Heart Sounds | 1 | 2017 | 17 | 0.570 |
Why?
|
Positron-Emission Tomography | 12 | 2024 | 6548 | 0.550 |
Why?
|
Autoimmunity | 1 | 2024 | 1361 | 0.520 |
Why?
|
Ventricular Dysfunction | 1 | 2017 | 143 | 0.520 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1567 | 0.520 |
Why?
|
Stethoscopes | 1 | 2015 | 30 | 0.500 |
Why?
|
Breast Feeding | 1 | 2023 | 1363 | 0.480 |
Why?
|
Skin Diseases | 1 | 2023 | 1084 | 0.470 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2257 | 0.460 |
Why?
|
Heart | 2 | 2023 | 4425 | 0.440 |
Why?
|
Biological Products | 1 | 2023 | 948 | 0.430 |
Why?
|
Thrombosis | 2 | 2024 | 2953 | 0.420 |
Why?
|
Cardiovascular System | 1 | 2020 | 839 | 0.400 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1750 | 0.400 |
Why?
|
Myocardium | 3 | 2024 | 4765 | 0.390 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2255 | 0.390 |
Why?
|
Ammonia | 2 | 2023 | 245 | 0.390 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2392 | 0.380 |
Why?
|
Lipoprotein(a) | 3 | 2024 | 489 | 0.370 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2011 | 72 | 0.360 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2306 | 0.360 |
Why?
|
Predictive Value of Tests | 6 | 2024 | 15425 | 0.360 |
Why?
|
Tomography, Optical Coherence | 1 | 2024 | 2954 | 0.360 |
Why?
|
Humans | 64 | 2024 | 766812 | 0.350 |
Why?
|
Cardiomyopathies | 1 | 2022 | 2058 | 0.340 |
Why?
|
Peptide Fragments | 1 | 2021 | 5143 | 0.310 |
Why?
|
Myocardial Infarction | 4 | 2024 | 11514 | 0.300 |
Why?
|
Tissue Donors | 1 | 2017 | 2392 | 0.290 |
Why?
|
Interleukin-6 | 3 | 2023 | 3226 | 0.270 |
Why?
|
Risk Factors | 14 | 2024 | 74889 | 0.250 |
Why?
|
Treatment Outcome | 9 | 2024 | 65286 | 0.250 |
Why?
|
Cell Lineage | 2 | 2011 | 2573 | 0.250 |
Why?
|
Janus Kinases | 2 | 2024 | 253 | 0.250 |
Why?
|
Cardiac Imaging Techniques | 2 | 2024 | 280 | 0.230 |
Why?
|
Immunotherapy | 1 | 2020 | 4747 | 0.220 |
Why?
|
Heart Transplantation | 1 | 2017 | 3306 | 0.220 |
Why?
|
Heart Failure | 4 | 2022 | 11879 | 0.210 |
Why?
|
Takayasu Arteritis | 1 | 2024 | 106 | 0.210 |
Why?
|
Registries | 3 | 2024 | 8352 | 0.210 |
Why?
|
Echocardiography | 1 | 2015 | 5038 | 0.210 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 163 | 0.210 |
Why?
|
Female | 31 | 2024 | 396532 | 0.200 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3266 | 0.200 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2024 | 1143 | 0.200 |
Why?
|
Hypertension | 4 | 2024 | 8616 | 0.200 |
Why?
|
Coronary Angiography | 2 | 2024 | 4525 | 0.190 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 2 | 2011 | 85 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2024 | 939 | 0.180 |
Why?
|
Early Growth Response Transcription Factors | 1 | 2020 | 32 | 0.180 |
Why?
|
C-Reactive Protein | 2 | 2024 | 3853 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 559 | 0.180 |
Why?
|
Aged | 15 | 2024 | 171344 | 0.180 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 308 | 0.170 |
Why?
|
Antigens, Human Platelet | 1 | 2020 | 41 | 0.170 |
Why?
|
Male | 25 | 2024 | 364154 | 0.170 |
Why?
|
Risk Assessment | 8 | 2024 | 24299 | 0.170 |
Why?
|
Pericardium | 1 | 2024 | 681 | 0.170 |
Why?
|
Drug Interactions | 1 | 2024 | 1419 | 0.170 |
Why?
|
Apolipoprotein A-I | 1 | 2021 | 305 | 0.170 |
Why?
|
T-Lymphocytes | 3 | 2011 | 10263 | 0.160 |
Why?
|
Middle Aged | 19 | 2024 | 223267 | 0.160 |
Why?
|
Apolipoproteins B | 1 | 2021 | 385 | 0.160 |
Why?
|
Interleukin-1 | 1 | 2023 | 1251 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 226 | 0.160 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 347 | 0.160 |
Why?
|
Prospective Studies | 6 | 2024 | 54872 | 0.160 |
Why?
|
Running | 1 | 2023 | 488 | 0.150 |
Why?
|
Calcium | 2 | 2023 | 5783 | 0.150 |
Why?
|
Lymphopoiesis | 1 | 2009 | 133 | 0.150 |
Why?
|
Interleukin-1beta | 1 | 2024 | 1026 | 0.150 |
Why?
|
Retinal Vessels | 1 | 2024 | 863 | 0.150 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 588 | 0.150 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 505 | 0.150 |
Why?
|
Viremia | 1 | 2020 | 727 | 0.140 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2020 | 577 | 0.140 |
Why?
|
Troponin | 1 | 2020 | 536 | 0.140 |
Why?
|
Action Potentials | 1 | 2024 | 1835 | 0.140 |
Why?
|
Vasodilator Agents | 1 | 2021 | 988 | 0.130 |
Why?
|
Retrospective Studies | 11 | 2024 | 81657 | 0.130 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 734 | 0.130 |
Why?
|
Cell Differentiation | 3 | 2011 | 11657 | 0.130 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2020 | 245 | 0.130 |
Why?
|
Prognosis | 7 | 2024 | 29959 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 3114 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2024 | 1203 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1256 | 0.120 |
Why?
|
Consensus | 1 | 2024 | 3208 | 0.110 |
Why?
|
Fatty Liver | 1 | 2020 | 810 | 0.110 |
Why?
|
Clinical Medicine | 1 | 2015 | 145 | 0.110 |
Why?
|
Aspirin | 2 | 2023 | 3134 | 0.110 |
Why?
|
Ischemia | 1 | 2023 | 1905 | 0.110 |
Why?
|
Myeloid Cells | 1 | 2009 | 838 | 0.110 |
Why?
|
Venous Thromboembolism | 2 | 2024 | 1883 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2270 | 0.110 |
Why?
|
Triglycerides | 1 | 2021 | 2441 | 0.110 |
Why?
|
History, 19th Century | 1 | 2015 | 714 | 0.110 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 582 | 0.100 |
Why?
|
Heart Rate | 1 | 2024 | 4207 | 0.100 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2823 | 0.100 |
Why?
|
Autoantigens | 1 | 2006 | 890 | 0.100 |
Why?
|
Cholesterol | 1 | 2021 | 2904 | 0.100 |
Why?
|
Kidney | 2 | 2024 | 7073 | 0.100 |
Why?
|
Receptor, Notch1 | 2 | 2011 | 518 | 0.090 |
Why?
|
Autoantibodies | 1 | 2020 | 2115 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2024 | 4215 | 0.090 |
Why?
|
Myeloid Progenitor Cells | 1 | 2011 | 112 | 0.090 |
Why?
|
Recurrence | 1 | 2023 | 8507 | 0.090 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2011 | 175 | 0.090 |
Why?
|
Genes, Essential | 1 | 2011 | 185 | 0.090 |
Why?
|
Animals | 10 | 2024 | 168939 | 0.080 |
Why?
|
Multipotent Stem Cells | 1 | 2011 | 200 | 0.080 |
Why?
|
Signal Transduction | 4 | 2024 | 23618 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2143 | 0.080 |
Why?
|
Drug Substitution | 2 | 2023 | 292 | 0.080 |
Why?
|
Up-Regulation | 2 | 2024 | 4143 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4278 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20710 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 2763 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5098 | 0.070 |
Why?
|
Hospitalization | 3 | 2024 | 10816 | 0.070 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2011 | 496 | 0.070 |
Why?
|
Pregnancy | 3 | 2024 | 30236 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12536 | 0.070 |
Why?
|
B-Cell Activating Factor | 1 | 2007 | 116 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2023 | 22248 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10384 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1217 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3989 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10580 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9358 | 0.070 |
Why?
|
B-Lymphocyte Subsets | 1 | 2007 | 240 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2011 | 1103 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5888 | 0.060 |
Why?
|
Mice, Inbred C57BL | 5 | 2020 | 22351 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 41706 | 0.060 |
Why?
|
Pericarditis, Constrictive | 1 | 2024 | 46 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2007 | 546 | 0.060 |
Why?
|
Stroke Volume | 3 | 2022 | 5618 | 0.050 |
Why?
|
Dideoxynucleosides | 1 | 2023 | 135 | 0.050 |
Why?
|
Obesity | 2 | 2024 | 13090 | 0.050 |
Why?
|
Lamivudine | 1 | 2023 | 367 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1885 | 0.050 |
Why?
|
HEK293 Cells | 1 | 2011 | 4277 | 0.050 |
Why?
|
Adult | 10 | 2024 | 223305 | 0.050 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2815 | 0.050 |
Why?
|
Oxazines | 1 | 2023 | 358 | 0.050 |
Why?
|
Bone Marrow | 1 | 2011 | 2926 | 0.050 |
Why?
|
Spleen | 1 | 2007 | 2295 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2009 | 18329 | 0.050 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2023 | 296 | 0.050 |
Why?
|
Alanine | 1 | 2023 | 613 | 0.050 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4033 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
B-Lymphocytes | 2 | 2009 | 4787 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 125 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 124 | 0.040 |
Why?
|
Pipecolic Acids | 1 | 2020 | 77 | 0.040 |
Why?
|
Mice | 7 | 2020 | 81898 | 0.040 |
Why?
|
Vaccination | 2 | 2022 | 3435 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 586 | 0.040 |
Why?
|
Diffusion of Innovation | 1 | 2024 | 724 | 0.040 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 2024 | 519 | 0.040 |
Why?
|
Culture Media, Serum-Free | 1 | 2009 | 147 | 0.040 |
Why?
|
Child, Preschool | 1 | 2022 | 42577 | 0.040 |
Why?
|
Perfusion | 1 | 2023 | 1409 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4570 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2024 | 12430 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2011 | 4401 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 818 | 0.040 |
Why?
|
Young Adult | 2 | 2022 | 59939 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2020 | 14473 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 18986 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1392 | 0.040 |
Why?
|
Coronary Thrombosis | 1 | 2020 | 440 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1641 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2085 | 0.040 |
Why?
|
Platelet Transfusion | 1 | 2020 | 301 | 0.040 |
Why?
|
HIV Infections | 1 | 2023 | 17532 | 0.030 |
Why?
|
Postpartum Period | 1 | 2024 | 1195 | 0.030 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1226 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2024 | 949 | 0.030 |
Why?
|
Arginine | 1 | 2020 | 932 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2078 | 0.030 |
Why?
|
Thymus Gland | 2 | 2011 | 1266 | 0.030 |
Why?
|
Antigens, CD19 | 1 | 2009 | 444 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21527 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15912 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20146 | 0.030 |
Why?
|
Prevalence | 2 | 2024 | 15835 | 0.030 |
Why?
|
Thrombectomy | 1 | 2020 | 676 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2011 | 5890 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 340 | 0.030 |
Why?
|
Shock, Cardiogenic | 1 | 2020 | 709 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2659 | 0.030 |
Why?
|
Models, Immunological | 1 | 2006 | 517 | 0.030 |
Why?
|
Nucleic Acids | 1 | 2006 | 189 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5022 | 0.030 |
Why?
|
Piperazines | 1 | 2023 | 2547 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2006 | 960 | 0.030 |
Why?
|
Cardiology | 1 | 2024 | 1701 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5306 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3803 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2022 | 2783 | 0.020 |
Why?
|
Warfarin | 1 | 2020 | 1493 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3385 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2053 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3213 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2011 | 12795 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1982 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4559 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6306 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2024 | 2971 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2011 | 826 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11924 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3317 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3384 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5502 | 0.020 |
Why?
|
Stents | 1 | 2020 | 3193 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8540 | 0.020 |
Why?
|
Anti-HIV Agents | 1 | 2023 | 4561 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9346 | 0.020 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 384 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3934 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3678 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2006 | 2328 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59548 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2011 | 812 | 0.020 |
Why?
|
Coronavirus Infections | 1 | 2024 | 3110 | 0.020 |
Why?
|
Pneumonia, Viral | 1 | 2024 | 3232 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1604 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2011 | 1716 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16722 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14762 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2392 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2007 | 794 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7571 | 0.010 |
Why?
|
Pandemics | 1 | 2024 | 8734 | 0.010 |
Why?
|
United States | 2 | 2024 | 72945 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18397 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13642 | 0.010 |
Why?
|
Calcium Signaling | 1 | 2007 | 736 | 0.010 |
Why?
|
Time Factors | 1 | 2024 | 40149 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26309 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6066 | 0.010 |
Why?
|
Base Sequence | 1 | 2011 | 12415 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18076 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2011 | 17609 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15564 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10451 | 0.010 |
Why?
|